Literature DB >> 19235861

Primary vasculitis of the central nervous system in patients infected with HIV-1 in the HAART era.

Giovanna Melica1, Pierre Brugieres, Anne-Sophie Lascaux, Yves Levy, Jean-Daniel Lelièvre.   

Abstract

Angiitis of the central nervous system (CNS) in patients infected with HIV-1-is often associated with concomitant infection or lymphoproliferative disease of the CNS. Four HAART naïve patients infected with HIV-1 with severe stroke are described. Evidence of vasculitis was found by magnetic resonance angiography. Extensive investigations excluded concomitant opportunistic, lymphoproliferative or autoimmune disorders leading to the diagnosis of primary angiitis of the CNS. Despite initiation of HAART and prolonged suppression of viral replication, these patients remained severely immunosuppressed. The addition of corticosteroids led to a significant improvement of clinical symptoms. Primary angiitis of the CNS should be considered in patients with HIV and stroke. The prognosis of these patients remain poor despite HAART. These observations suggest that the vascular inflammatory process persists despite the control of viral load under HAART in patients with persistent immunosuppression. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19235861     DOI: 10.1002/jmv.21462

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

1.  The "milky way" galaxy of HIV-related central nervous system immune reaction syndromes.

Authors:  Mattia Trunfio; Claudia Manini; Alice Trentalange; Andrea Boghi; Sabrina Audagnotto; Daniele Imperiale; Stefano Taraglio; Stefano Bonora; Giovanni Di Perri; Andrea Calcagno
Journal:  J Neurovirol       Date:  2019-06-18       Impact factor: 2.643

2.  Human immunodeficiency virus-associated cytomegalovirus infection with multiple small vessel cerebral infarcts in the setting of early immune reconstitution.

Authors:  Albert M Anderson; Jack A Fountain; Sonya B Green; Sharon A Bloom; Melody P Palmore
Journal:  J Neurovirol       Date:  2010-03       Impact factor: 2.643

Review 3.  CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 2: discussion of neuro-immune reconstitution inflammatory syndrome with and without other pathogens.

Authors:  M J D Post; M M Thurnher; D B Clifford; A Nath; R G Gonzalez; R K Gupta; K K Post
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

4.  Ischemic Stroke in an HIV Positive Patient: An Initial Presentation of Neurosyphilis.

Authors:  Kalimullah Jan; Rebecca Hoe Hui Min; Tan Seow Yen; Shekhawat Ravindra Singh
Journal:  Case Rep Neurol Med       Date:  2018-02-13

5.  Response of Human Immunodeficiency Virus-Associated Cerebral Angiitis to the Combined Antiretroviral Therapy.

Authors:  Julian Cheron; Chloé Wyndham-Thomas; Niloufar Sadeghi; Gilles Naeije
Journal:  Front Neurol       Date:  2017-03-13       Impact factor: 4.003

Review 6.  HIV infection and stroke: current perspectives and future directions.

Authors:  Laura A Benjamin; Alan Bryer; Hedley C A Emsley; Saye Khoo; Tom Solomon; Myles D Connor
Journal:  Lancet Neurol       Date:  2012-10       Impact factor: 44.182

7.  Arterial ischemic stroke in HIV: Defining and classifying etiology for research studies.

Authors:  Laura A Benjamin; Alan Bryer; Sebastian Lucas; Alan Stanley; Theresa J Allain; Elizabeth Joekes; Hedley Emsley; Ian Turnbull; Colin Downey; Cheng-Hock Toh; Kevin Brown; David Brown; Catherine Ison; Colin Smith; Elizabeth L Corbett; Avindra Nath; Robert S Heyderman; Myles D Connor; Tom Solomon
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-06-30

Review 8.  Vasculitides in HIV Infection.

Authors:  Luis E Vega; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2020-08-26       Impact factor: 4.592

9.  Reversible Small Vessel Vasculitis and Encephalitis in HIV Antiretroviral Resistance.

Authors:  Ryan T Muir; Suradech Suthiphosuwan; Aditya Bharatha; Amy Lin; David Munoz; Mario Ostrowski; Raphael Schneider
Journal:  J Neuropathol Exp Neurol       Date:  2021-01-01       Impact factor: 3.685

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.